RGNX earnings
REGENXBIO (RGNX) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
RGNX earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Aug 6, 2026 | 0.43 | 0.08 | 446.17% | $108.02M |
| Q1 2026 | May 14, 2026 | -1.72 | -1.36 | -26.47% | $6.39M |
| Q4 2025 | Mar 5, 2026 | -1.30 | -1.01 | -28.71% | $30.34M |
| Q3 2025 | Nov 6, 2025 | -1.20 | -1.38 | 13.04% | $29.73M |
| Q2 2025 | Aug 7, 2025 | -1.38 | -1.13 | -22.12% | $21.36M |
| Q1 2025 | May 12, 2025 | 0.12 | 0.41 | -70.73% | $89.01M |
| Q4 2024 | Mar 13, 2025 | -1.01 | -1.27 | 20.47% | $21.21M |
| Q3 2024 | Nov 6, 2024 | -1.17 | -1.16 | -0.86% | $24.20M |
| Q2 2024 | Aug 1, 2024 | -1.05 | -1.29 | 18.60% | $22.30M |
| Q1 2024 | May 8, 2024 | -1.38 | -1.28 | -7.81% | $15.62M |
| Q4 2023 | Feb 27, 2024 | -1.43 | -1.27 | -12.60% | $22.21M |
| Q3 2023 | Nov 8, 2023 | -1.41 | -1.44 | 2.08% | $28.91M |
| Aug 2, 2023 | -1.66 | -1.26 | -31.75% | – | |
| May 3, 2023 | -1.53 | -1.52 | -0.66% | – | |
| Feb 28, 2023 | -1.38 | -1.48 | 6.76% | – | |
| Nov 3, 2022 | -1.75 | -1.55 | -12.90% | – | |
| Aug 3, 2022 | -1.58 | -1.44 | -9.72% | – | |
| May 4, 2022 | -1.62 | -1.29 | -25.58% | – | |
| Mar 1, 2022 | 6.67 | 4.71 | 41.61% | – | |
| Nov 2, 2021 | -1.37 | -0.87 | -57.47% | – |
- RGNX reports next on Nov 5, 2026, with EPS of -1.26 expected.
- RGNX beat EPS estimates in 16 of its last 43 reports.
Updated 2026-11-05 12:50 UTC